Compare Abbott Laboratories (ABT) vs First Trust NASDAQ Cybersecurity ETF (CIBR) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs First Trust NASDAQ Cybersecurity ETF — how do they compare? Abbott Laboratories trades at $94.9 (market cap $166.94B), while First Trust NASDAQ Cybersecurity ETF trades at $91.57. The key difference: Abbott Laboratories pays a 2.63% dividend while First Trust NASDAQ Cybersecurity ETF pays none, and First Trust NASDAQ Cybersecurity ETF is trading nearer its 52-week high, Abbott Laboratories nearer its low. Which is the better fit depends on your goals.
| ABT | CIBR | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | — |
52-Week High | $136.62 | $94.32 |
52-Week Low | $82.57 | $60.74 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
CIBR (First Trust NASDAQ Cybersecurity ETF) trades at $92.21, up 1.7% with strong bullish momentum. Technical indicators show moving averages in bullish alignment while oscillators signal neutral conditions. The ETF has significantly outperformed the S&P 500, gaining approximately 22% year-to-date through June 2026 versus 8% for the broader market. Recent news highlights growing cybersecurity spending exceeding $300 billion globally, with CIBR positioned as a clean play on AI-driven security demand.
The cybersecurity sector benefits from structural growth drivers including AI-powered threats and mandatory corporate spending. CIBR offers diversified exposure to 30+ cybersecurity companies with reasonable valuation at 24x P/E. Key risks include concentrated tech exposure and market volatility, but institutional buying and positive analyst sentiment support the bullish outlook for this thematic ETF.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About First Trust NASDAQ Cybersecurity ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index includes securities of companies classified as cyber security companies. The fund is non-diversified.
Read more on CIBR →
